Whatdyamean if all the current trials fail? That is simply not going to happen. In some ways having just acne in phase 2 may have been a little simpler wouldn't you think? The phase 1b's were outstanding for us and so we await the phase 2 acne results. IF they are supurb, this is a company maker. But lo and behold our Matt went on a bundy bender one night after the phase 1b atopic dermatitis results came out and personally wasnt happy and wanted this to be a second company maker. Then he hit the after dinner drinks like Tia maria and I am SURE green absinthe because our Matt suddenly thinks that he can get a third company maker with psoriasis. Slow down Matt, lets not turn a pimple into a mountain.
But that's exactly what this dude is doing....and quickly. And after the postings towards the end of last week, I am hoping we now know why !
The market is the market but one day can change your life.
- Forums
- ASX - By Stock
- BOT
- Bot Chart
Bot Chart, page-194
- There are more pages in this discussion • 11,979 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $346.5M |
Open | High | Low | Value | Volume |
22.0¢ | 22.0¢ | 21.5¢ | $556.8K | 2.564M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.0¢ | 188599 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.215 |
29 | 1479591 | 0.210 |
15 | 1276382 | 0.205 |
27 | 823944 | 0.200 |
19 | 728465 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.220 | 188599 | 5 |
0.225 | 1142115 | 6 |
0.230 | 411498 | 11 |
0.235 | 628123 | 12 |
0.240 | 750759 | 14 |
Last trade - 16.10pm 30/04/2024 (20 minute delay) ? |
|
|||||
Last
21.8¢ |
  |
Change
0.000 ( 1.09 %) |
|||
Open | High | Low | Volume | ||
22.0¢ | 22.0¢ | 21.5¢ | 1397313 | ||
Last updated 15.59pm 30/04/2024 ? |
Featured News
BOT (ASX) Chart |